chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Lymph node pain, Lymphadenopathy
Clinical narrative: tender lymph gland (near collarbone, on same side as vaccinated arm); swollen lymph gland (near collarbone, on same side as vaccinated arm); Nausea; Headache; diarrhea; General tiredness; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 27Mar2021 at 10:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included statin (MANAFACTURER UNKNOWN) 40 mg, multi vitamin (MANAFACTURER UNKNOWN) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 the patient experienced tiredness, and on 01Apr2021 experienced nausea, headache, diarrhea, swollen lymph nodes, lymph node tenderness. It was reported that swollen and tender lymph gland near collarbone, on same side as vaccinated arm. Lymph gland was still swollen - 8 days later. The patient did not receive treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Clinical outcome of tiredness, nausea, headache, diarrhea, swollen lymph nodes, lymph node tenderness was not recovered at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: tender lymph gland (near collarbone, on same side as vaccinated arm); swollen lymph gland (near collarbone, on same side as vaccinated arm); Nausea; Headache; diarrhea; General tiredness; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 27Mar2021 at 10:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included statin (MANAFACTURER UNKNOWN) 40 mg, multi vitamin (MANAFACTURER UNKNOWN) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 the patient experienced tiredness, and on 01Apr2021 experienced nausea, headache, diarrhea, swollen lymph nodes, lymph node tenderness. It was reported that swollen and tender lymph gland near collarbone, on same side as vaccinated arm. Lymph gland was still swollen - 8 days later. The patient did not receive treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Clinical outcome of tiredness, nausea, headache, diarrhea, swollen lymph nodes, lymph node tenderness was not recovered at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Muscle twitching
Clinical narrative: Twitching; Muscle spasms  near the shot site every few minutes; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er8733) via an unspecified route of administration in the left arm on 02Apr2021 at 15:00 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included Hashimoto's disease, anaemia, shellfish allergy, cockroach allergy and fruit allergy (allergy to tomatoes). Concomitant medications included sertraline hydrochloride (ZOLOFT), levothyroxine (MANUFACTURER UNKNOWN) and fexofenadine hydrochloride (ALLEGRA) all for unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 12:00 the patient experienced twitching/muscle spasms near the shot site every few minutes. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event twitching and muscle spasms was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertension
Clinical narrative: High blood pressure; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8733) via an unspecified route of administration in the left arm on 24Mar2021 at 15:45 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high and penicillin allergy. The patient received other medications(unspecified) within 2 weeks of COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 26Mar2021 on 12:00, the patient experienced high blood pressure. The treatment received for the reported event was unknown. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event high blood pressure was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Malaise, Menstruation irregular, Nausea
Clinical narrative: period within 2 hours of the vaccination (not near the date where I was supposed to have my period); tired; feeling unwell; nausea; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the arm left on 15Mar2021 at 09:30 (at the age of 44-year-old) as a single dose for COVID-19 immunisation and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the arm left on 05Apr2021 at 09:45 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergy to penicillin. The patient did not take any concomitant medication. The patient previously took Augmentin on unknown date for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Since the vaccination, the patient had not been tested for COVID-19. On 15Mar2021 at 11:30 within 2 hours of the vaccination, the patient experienced period (not near the date where she was supposed to have her period), tired, feeling unwell and nausea.  The clinical outcome of the event period (not near the date where she was supposed to have her period), tired, feeling unwell and nausea was unknown. On 05Apr2021 at 11:30 within 2 hours of the vaccination, the patient experienced period (not near the date where she was supposed to have her period), tired, feeling unwell and nausea. The clinical outcomes of the events period within 2 hours of the vaccination, tired, feeling unwell and nausea were recovered on an unknown date in Apr2021. The patient did not receive treatment for the adverse events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Lymph node in left armpit tender; Swollen Lymph node in left armpit; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 03Apr2021 at 13:30 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 06Mar2021 at 13:30 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Apr2021 at 21:30, the patient experienced swollen lymph node in left armpit, which was also tender for a limited time. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events of lymph node tenderness and axillary lymph nodes enlarged were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pruritus, SARS-CoV-2 test, Skin lesion
Clinical narrative: Itchy; Red, bumpy skin around upper body; noticeable itchy, red, bumpyskin around my upper body, especiallyleft and right sides of upper body,neck, chest.; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6207) via an unspecified route of administration in the left arm on 23Mar2021 at 15:00(at the age of 25-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to cats, dusts and  mite allergy. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), ascorbic acid (VITAMIN C), cannabidiol (CBD OIL) and THC, all from unknown dates and for unspecified indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 23Mar2021, the patient underwent PCR(nasal swab) test and the result was negative. On 29Mar2021 at 13:00 6th day of vaccination, the patient experienced itchy, red, bumpy skin(skin lesions NOS) around upper body especially left and right sides of upper body, neck, chest. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment for the reported events which included benadryl once in the evening on 29Mar2021 and the symptoms were gone and returned mindly on the 30Mar2021.The patient took claritin instead for two extra days and stopped, all symptoms were gone. The clinical outcome of the event itchy, red, bumpy skin around upper body was recovered on unspecified date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Vaccination site erythema, Vaccination site mass
Clinical narrative: Red bump at site of injection; Nausea; Headache; Tiredness; dark mark on my skin where the redbump was and it's been three weeks; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Mar2021 at 14:00 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. No relevant medical history. Concomitant medications included sertraline hydrochloride (ZOLOFT) and trazodone (MANUFACTURER UNKNOWN) started from unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient not diagnosed with COVID-19. Since the vaccination, the patient not been tested for COVID-19. On 15Mar2021 at 14:15 the patient experienced nausea, headache, tiredness and red bump at site of injection(vaccination site erythema). She also had a dark mark on her skin where the red bump(vaccination site lump) was and it had been three weeks. The patient did not receive any treatment for the events. The events did not result in any of these doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event nausea, headache, tiredness, red bump at site of injection and a dark mark on her skin where the red bump was recovered on unknown date in 2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Chills, Headache, Nausea, Neck pain
Clinical narrative: Chills; body aches; nausea; vomiting; headache; skin sensitivity; abdominal pain; pain in injection site; pain in neck on side of injection site; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the arm right on 01Apr2021 at 11:45 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included birth Control Pill, fexofenadine hydrochloride (ALLEGRA), paracetamol (TYLENOL), mefenamic acid (ADVIL). The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the arm right on 09Mar2021 at 14:30 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient previously took Codeine and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 03:15 the patient experienced chills, body aches, nausea, vomiting, headache, skin sensitivity, abdominal pain, pain in the injection site and pain in neck on side of injection site. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visits, and the emergency room/department or urgent care. The clinical outcome of the event chills, body aches, nausea, vomiting, headache, skin sensitivity, abdominal pain, pain in the injection site and pain in neck on side of the injection site was recovering at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Sensitive skin, Vaccination site pain, Vomiting
Clinical narrative: Chills; body aches; nausea; vomiting; headache; skin sensitivity; abdominal pain; pain in injection site; pain in neck on side of injection site; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the arm right on 01Apr2021 at 11:45 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included birth Control Pill, fexofenadine hydrochloride (ALLEGRA), paracetamol (TYLENOL), mefenamic acid (ADVIL). The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the arm right on 09Mar2021 at 14:30 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient previously took Codeine and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 03:15 the patient experienced chills, body aches, nausea, vomiting, headache, skin sensitivity, abdominal pain, pain in the injection site and pain in neck on side of injection site. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visits, and the emergency room/department or urgent care. The clinical outcome of the event chills, body aches, nausea, vomiting, headache, skin sensitivity, abdominal pain, pain in the injection site and pain in neck on side of the injection site was recovering at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Nausea
Clinical narrative: severe headache; nausea; fatigue; chills; body ache; 100 degree fever; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 02Apr2021 at 09:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, depression and pain pelvic. The patient was allergic to melon and bermuda grass. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included lithium (MANUFACTURER UNKNOWN), sertraline (MANUFACTURER UNKNOWN), lamotrigine (LAMICTAL) and levomefolic acid (METHYLFOLAT). The patient previously received PERCOCET for unknown indication and experienced drug allergy. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 15:00, the patient experienced severe headache, nausea, fatigue, chills, body aches and 100-degree fever. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of events severe headache, nausea, fatigue, chills, body aches and 100-degree fever were resolving at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: severe headache; nausea; fatigue; chills; body ache; 100 degree fever; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 02Apr2021 at 09:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, depression and pain pelvic. The patient was allergic to melon and bermuda grass. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included lithium (MANUFACTURER UNKNOWN), sertraline (MANUFACTURER UNKNOWN), lamotrigine (LAMICTAL) and levomefolic acid (METHYLFOLAT). The patient previously received PERCOCET for unknown indication and experienced drug allergy. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 15:00, the patient experienced severe headache, nausea, fatigue, chills, body aches and 100-degree fever. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of events severe headache, nausea, fatigue, chills, body aches and 100-degree fever were resolving at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal
Clinical narrative: Lightheaded and dizziness; Brain fog; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 05Apr2021 at 15:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included dysautonomia and POTS (postural orthostatic tachycardia syndrome); both from an unknown date. The patient did not have any allergies to medications, food, or other products. Concomitant medications included nadolol (MANUFACTURER UNKNOWN), ciclosporin (RESTASIS), magnesium (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C), vitamin d nos (VITAMIN D) and ubidecarenone (COQ); all from an unknown date for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 15:15, the patient experienced lightheaded and dizziness and brain fog. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events lightheaded and dizziness and brain fog was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Paraesthesia
Clinical narrative: Sore arm at shot location; Pins and needles sensation upper body; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9809) via an unspecified route of administration in the arm left on 04Feb2021 at 13:00(at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Feb2021 the patient experienced sore arm at shot location and pins and needles sensation upper body. Sore arm was still present 10 weeks after the shot at the shot location and pins and needles sensation in upper body off and on still. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events sore arm and pins and needles sensation upper body was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Body mass index, Body temperature, Dizziness
Clinical narrative: Fever of 101; Feel crappy; Tired; Seeing spots; Pulse up to 120; B/p was 160; Light headed; Tingly; This is a spontaneous report from a contactable nurse, the patient. A 56-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 24Mar2021 at 11:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity and known allergies as blotchy and sensitive skin. Concomitant medications included cetirizine hydrochloride (ZYRTEC) 1 per day, 2000 units of colecalciferol (VITAMIN D3) and 500mg of ascorbic acid (VITAMIN C); all from an unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021, 10minutes after the shot, the patient was driving and started seeing spots, pulse was up to 120, blood pressure was 160 at the fire station. Light headed and tingly. Done in 3 hours and left ED. Next day (25Mar2021), the patient experienced just tired. On day 5, (29Mar2021), the patient experienced fever of 101 and felt crappy. The patient took ibuprofen. The patient would talk to an allergist before taking the second one. Her risk factor was obesity BMI of 40. The events seeing spots, pulse was up to 120, blood pressure was 160, light headed and tingly resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of fever of 101, felt crappy and included treatment with ibuprofen (MANUFACTURER UNKNOWN). The clinical outcomes of spots, pulse up to 120, blood pressure was 160, light headed, tingly were recovered with sequelae on 24Mar2021. The clinical outcomes of tiredness, fever of 101, felt crappy were recovered with sequelae on an unknown date in 2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Heart rate, Heart rate increased, Malaise, Paraesthesia
Clinical narrative: Fever of 101; Feel crappy; Tired; Seeing spots; Pulse up to 120; B/p was 160; Light headed; Tingly; This is a spontaneous report from a contactable nurse, the patient. A 56-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 24Mar2021 at 11:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity and known allergies as blotchy and sensitive skin. Concomitant medications included cetirizine hydrochloride (ZYRTEC) 1 per day, 2000 units of colecalciferol (VITAMIN D3) and 500mg of ascorbic acid (VITAMIN C); all from an unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021, 10minutes after the shot, the patient was driving and started seeing spots, pulse was up to 120, blood pressure was 160 at the fire station. Light headed and tingly. Done in 3 hours and left ED. Next day (25Mar2021), the patient experienced just tired. On day 5, (29Mar2021), the patient experienced fever of 101 and felt crappy. The patient took ibuprofen. The patient would talk to an allergist before taking the second one. Her risk factor was obesity BMI of 40. The events seeing spots, pulse was up to 120, blood pressure was 160, light headed and tingly resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of fever of 101, felt crappy and included treatment with ibuprofen (MANUFACTURER UNKNOWN). The clinical outcomes of spots, pulse up to 120, blood pressure was 160, light headed, tingly were recovered with sequelae on 24Mar2021. The clinical outcomes of tiredness, fever of 101, felt crappy were recovered with sequelae on an unknown date in 2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash macular
Clinical narrative: Fever of 101; Feel crappy; Tired; Seeing spots; Pulse up to 120; B/p was 160; Light headed; Tingly; This is a spontaneous report from a contactable nurse, the patient. A 56-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 24Mar2021 at 11:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity and known allergies as blotchy and sensitive skin. Concomitant medications included cetirizine hydrochloride (ZYRTEC) 1 per day, 2000 units of colecalciferol (VITAMIN D3) and 500mg of ascorbic acid (VITAMIN C); all from an unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021, 10minutes after the shot, the patient was driving and started seeing spots, pulse was up to 120, blood pressure was 160 at the fire station. Light headed and tingly. Done in 3 hours and left ED. Next day (25Mar2021), the patient experienced just tired. On day 5, (29Mar2021), the patient experienced fever of 101 and felt crappy. The patient took ibuprofen. The patient would talk to an allergist before taking the second one. Her risk factor was obesity BMI of 40. The events seeing spots, pulse was up to 120, blood pressure was 160, light headed and tingly resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of fever of 101, felt crappy and included treatment with ibuprofen (MANUFACTURER UNKNOWN). The clinical outcomes of spots, pulse up to 120, blood pressure was 160, light headed, tingly were recovered with sequelae on 24Mar2021. The clinical outcomes of tiredness, fever of 101, felt crappy were recovered with sequelae on an unknown date in 2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral sensory neuropathy
Clinical narrative: sensory neuropathy; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 20Mar2021 at 14:30 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included peripheral sensory neuropathy. The patient did not have any allergies to food, medications, or other products. Concomitant medications included regular duloxetine (MANUFACTURER UNKNOWN) 30mg and rosuvastatin calcium (CRESTOR) 10mg. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021 at 13:00 the patient experienced sensory neuropathy. It was reported that the patient had a minor sensory neuropathy at the lower extremes before the shot and it clearly flared up after the first shot. It seemed to be better at the time of this report. The event did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event sensory neuropathy was resolving at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Pins and needles/tingling in right fingers; Numbness in right fingers; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 01Apr2021 at 13:15 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included liposarcoma (cancer) in right leg in 2007, radiation and surgery to treat liposarcoma in 2007 and preeclampsia during pregnancy in 2017. The patient was allergic to penicillin. Concomitant medications included vitamin d (MANUFACTURER UNKNOWN), prenatal vitamin, probiotic and calcium (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 00:00, the patient experienced needles/tingling/numbness in her right fingers. It was in her middle finger, ring finger and pinkie finger. It went between the entire finger and from the middle knuckle up to the tip. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for events. The clinical outcome of the events pins and needles/tingling in right fingers and numbness in right fingers were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: One hour after the shot I had hives from the shot site to my wrist, stomach, and hives on my ankles.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Apr2021 at 18:45 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) for an unknown indication from an unspecified date. The patient previously received  Ibuprofen (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 03Apr2021 at 19:45, one hour after the vaccination, the patient experienced hives from the shot site to her wrist, stomach, and hives on her ankles, that lasted for 4 hours. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event hives from the shot site to her wrist, stomach, and hives on her ankles was recovered on 03Apr2021 at 23:45.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: Soreness in injection site muscle; significant fatigue; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 30Mar2021(at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma (predisposition to walking pneumonia). The patient did not have any allergies to medications, food, or other products. Concomitant medications included naproxen sodium (ALEVE) which was taken 1 week prior, on an unknown date and for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 30Mar2021 the patient experienced soreness in injection site muscle (vaccination site pain) and significant fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported adverse event.  The clinical outcome of the event soreness in injection site muscle (vaccination site pain) and significant fatigue was recovered on an unknown date in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: swollen lymph node on left collar bone.; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8727) via an unspecified route of administration in the left arm on 28Mar2021 at 15:45 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no allergies to medications, food, or other products. On 01Apr2021 at 08:00, the patient experienced swollen lymph node on her left collar bone. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event swollen lymph node on left collar bone was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Paraesthesia
Clinical narrative: chills; tiredness; joint aches; left side of face tingle; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 01Apr2021 at 16:30 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had intermittent shellfish allergies and only certain shellfish trigger allergic reactions but it's very rare. Concomitant medications included famotidine (MANUFACTURER UNKNOWN) 20 mg taken once daily from an unknown date for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 10:00 the patient experienced chills, tiredness, joint aches and left side of face tingle. The events did not result in doctor or other health care professional office/clinic visits, and the emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events chills, tiredness, joint aches and left side of face tingle were recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Dizziness, Erythema, Paraesthesia oral, Pharyngeal hypoaesthesia
Clinical narrative: Slight confusion; Slight dizziness; Itching; Redness of skin; Some numbness of throat; Tingling lips; This is a spontaneous report from a contactable consumer, the patient. A 34-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the arm right on 05Apr2021 at 14:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. It was unknown whether the patient had any known allergies to medications, food or other products. Concomitant medications included vitamin D nos (VITAMIN D) 50,000 IU, levothyroxine (MANUFACTURER UNKNOWN) 100 mg and vitamin E nos (VITAMIN E) all for an unknown indications, from an unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 14:30 the patient experienced slight confusion which abated within first 5 minutes after injection, slight dizziness, itching, redness of skin, some numbness of throat and  tingling lips. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of reported events. The clinical outcome of the event slight confusion which abated within first 5 minutes after injection i.e. 05Apr2021 at 14:35, slight dizziness, itching, redness of skin, some numbness of throat and tingling lips was recovered on 05Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Slight confusion; Slight dizziness; Itching; Redness of skin; Some numbness of throat; Tingling lips; This is a spontaneous report from a contactable consumer, the patient. A 34-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the arm right on 05Apr2021 at 14:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. It was unknown whether the patient had any known allergies to medications, food or other products. Concomitant medications included vitamin D nos (VITAMIN D) 50,000 IU, levothyroxine (MANUFACTURER UNKNOWN) 100 mg and vitamin E nos (VITAMIN E) all for an unknown indications, from an unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 14:30 the patient experienced slight confusion which abated within first 5 minutes after injection, slight dizziness, itching, redness of skin, some numbness of throat and  tingling lips. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of reported events. The clinical outcome of the event slight confusion which abated within first 5 minutes after injection i.e. 05Apr2021 at 14:35, slight dizziness, itching, redness of skin, some numbness of throat and tingling lips was recovered on 05Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Body temperature, Fatigue, Pyrexia, Vaccination site pain
Clinical narrative: Lots of back pain; Fever of 99 F; Severe arm soreness at injection location; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EU6207), via an unspecified route of administration in the left arm on 22Mar2021 at 13:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included inflammatory arthritis. Concomitant medications included sulfasalazine (SULFASALAZINE), methotrexate (METHOTREXATE), meloxicam (MELOXICAM) and folic acid (FOLIC ACID) all taken from unknown dates for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unknown date in 2021, the patient experienced a fever of 99-degree Fahrenheit for 4 hours, severe arm soreness at injection location (vaccination site pain), lots of back pain and fatigue. The events did not result in a doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the events experienced. The clinical outcome of the events lots of back pain, fever of 99-degree Fahrenheit, severe arm soreness at injection location (vaccination site pain) and fatigue was resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Hypoaesthesia, Joint swelling, Peripheral swelling
Clinical narrative: Severe joint pain in toes; Numbness of feet; swelling of the foot and ankle both feet are affected the left foot is the worst; swelling of the foot and ankle both feet are affected the left foot is the worst; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 23Mar2021 at 09:30 (at the age of 73-year-old) as single dose for COVID-19 immunisation. Medical history included coronary heart disease. The patient received unspecified medication within two weeks, Prior to vaccination. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccination within 4 weeks prior to the COVID vaccine. On 26Mar2021 at 15:45, the patient experienced severe joint pain in toes, numbness of feet and swelling of the foot and ankle both feet were affected the left foot was the worst. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the reported event. The clinical outcome of the events severe joint pain in toes, numbness of feet, swelling of the foot and ankle both feet are affected the left foot is the worst were not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.